arrow
R

Ronenn Roubenoff

Novartis
H指数:100
被引数:3.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early development of LRX712, preclinical chondroanabolic findings and results from a randomized first-in-human study

LRX712的早期开发、非临床软骨再生发现及来自一项随机首次人体研究的成果

2026-09-180
OAAI
Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial

血管生成素样3衍生物LNA043用于骨关节炎软骨再生: 一项随机1期试验

2022-12-0129
OAAI
Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project)
2022-05-11139
OAAI
Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults A Randomized Clinical Trial
2020-10-1986
OAAI
Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement Exploratory Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial

白细胞介素-1β 抑制对髋关节和膝关节置换事件的影响来自一项随机,双盲,安慰剂对照试验的探索性分析

2020-10-06106
OAAI
Continuous Digital Monitoring of Walking Speed in Frail Elderly Patients: Noninterventional Validation Study and Longitudinal Clinical Trial

老年体弱患者步行速度的连续数字监测: 非干预性验证研究和纵向临床试验

2019-11-2734
OAAI
The Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies (SPRINTT) randomized controlled trial: Case finding, screening and characteristics of eligible participants
2018-11-0159
OAAI